









Markets
/
Stocks
/
nasdaq-fblg
/

Fibrobiologics Inc

FBLG

View Detailed Chart

0.624USD

-0.025-3.78%

Market hours （ET）Quotes delayed by 15 min

25.50MMarket Cap

LossP/E TTM



Fibrobiologics Inc

0.624

-0.025-3.78%

Overview Company Financials

Financials

Intraday

30m

Today

-3.78%

5 Days

-7.77%

1 Month

+1.98%

6 Months

-61.48%

Year to Date

-68.80%

1 Year

-87.18%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

10.667

Target Price

1544.57%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Fibrobiologics Inc

FBLG

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(4)

Buy(1)

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.008

Neutral

RSI(14)

45.042

Neutral

STOCH(KDJ)(9,3,3)

42.676

Neutral

ATR(14)

0.057

Low Volatility

CCI(14)

-76.021

Neutral

Williams %R

55.462

Sell

TRIX(12,20)

-0.386

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.637

Sell

MA10

0.652

Sell

MA20

0.654

Sell

MA50

0.726

Sell

MA100

0.863

Sell

MA200

1.521

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

FibroBiologics, Inc. is a cell therapy regenerative medicine company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). The Company is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat Multiple sclerosis (MS) and has completed the Phase I study. The Company is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing.

Ticker SymbolFBLG

CompanyFibrobiologics Inc

CEOMr. Pete O'Heeron

Websitehttps://fibrobiologics.com/